 | • レポートコード：GIR-2104Z11436 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、前臨床CRO治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前臨床CRO治療の種類別市場規模（生物分析・DMPK研究、毒性試験、その他）、用途別市場規模（バイオ医薬品産業、政府・学術機関、医療機器産業）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・前臨床CRO治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Charles River Laboratories、Laboratory Corporation of America、Envigo、Eurofins Scientific、PRA Health Science、Wuxi AppTec、Medpace、Pharmaceutical Product Development、Paraxel ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：生物分析・DMPK研究、毒性試験、その他 ・用途別分析2016年-2026年：バイオ医薬品産業、政府・学術機関、医療機器産業 ・前臨床CRO治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・前臨床CRO治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・前臨床CRO治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・前臨床CRO治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・前臨床CRO治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Preclinical CRO Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Preclinical CRO Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Preclinical CRO Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Preclinical CRO Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bioanalysis and DMPK Studies
Toxicology Testing
Others
Market segment by Application, can be divided into
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
Market segment by players, this report covers
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi AppTec
Medpace
Pharmaceutical Product Development
Paraxel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Preclinical CRO Treatment
1.2 Classification of Preclinical CRO Treatment by Type
1.2.1 Overview: Global Preclinical CRO Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Preclinical CRO Treatment Revenue Market Share by Type in 2020
1.2.3 Bioanalysis and DMPK Studies
1.2.4 Toxicology Testing
1.2.5 Others
1.3 Global Preclinical CRO Treatment Market by Application
1.3.1 Overview: Global Preclinical CRO Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Medical Device Companies
1.4 Global Preclinical CRO Treatment Market Size & Forecast
1.5 Global Preclinical CRO Treatment Market Size and Forecast by Region
1.5.1 Global Preclinical CRO Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Preclinical CRO Treatment Market Size by Region, (2016-2021)
1.5.3 North America Preclinical CRO Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Preclinical CRO Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Preclinical CRO Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Preclinical CRO Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Preclinical CRO Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Preclinical CRO Treatment Market Drivers
1.6.2 Preclinical CRO Treatment Market Restraints
1.6.3 Preclinical CRO Treatment Trends Analysis
2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Preclinical CRO Treatment Product and Solutions
2.1.4 Charles River Laboratories Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 Laboratory Corporation of America
2.2.1 Laboratory Corporation of America Details
2.2.2 Laboratory Corporation of America Major Business
2.2.3 Laboratory Corporation of America Preclinical CRO Treatment Product and Solutions
2.2.4 Laboratory Corporation of America Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Laboratory Corporation of America Recent Developments and Future Plans
2.3 Envigo
2.3.1 Envigo Details
2.3.2 Envigo Major Business
2.3.3 Envigo Preclinical CRO Treatment Product and Solutions
2.3.4 Envigo Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Envigo Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Preclinical CRO Treatment Product and Solutions
2.4.4 Eurofins Scientific Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 PRA Health Science
2.5.1 PRA Health Science Details
2.5.2 PRA Health Science Major Business
2.5.3 PRA Health Science Preclinical CRO Treatment Product and Solutions
2.5.4 PRA Health Science Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 PRA Health Science Recent Developments and Future Plans
2.6 Wuxi AppTec
2.6.1 Wuxi AppTec Details
2.6.2 Wuxi AppTec Major Business
2.6.3 Wuxi AppTec Preclinical CRO Treatment Product and Solutions
2.6.4 Wuxi AppTec Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Wuxi AppTec Recent Developments and Future Plans
2.7 Medpace
2.7.1 Medpace Details
2.7.2 Medpace Major Business
2.7.3 Medpace Preclinical CRO Treatment Product and Solutions
2.7.4 Medpace Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Medpace Recent Developments and Future Plans
2.8 Pharmaceutical Product Development
2.8.1 Pharmaceutical Product Development Details
2.8.2 Pharmaceutical Product Development Major Business
2.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Product and Solutions
2.8.4 Pharmaceutical Product Development Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pharmaceutical Product Development Recent Developments and Future Plans
2.9 Paraxel
2.9.1 Paraxel Details
2.9.2 Paraxel Major Business
2.9.3 Paraxel Preclinical CRO Treatment Product and Solutions
2.9.4 Paraxel Preclinical CRO Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Paraxel Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Preclinical CRO Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Preclinical CRO Treatment Players Market Share
3.2.2 Top 10 Preclinical CRO Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Preclinical CRO Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Preclinical CRO Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Preclinical CRO Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Preclinical CRO Treatment Revenue Market Share by Application (2016-2021)
5.2 Preclinical CRO Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Preclinical CRO Treatment Revenue by Type (2016-2026)
6.2 North America Preclinical CRO Treatment Revenue by Application (2016-2026)
6.3 North America Preclinical CRO Treatment Market Size by Country
6.3.1 North America Preclinical CRO Treatment Revenue by Country (2016-2026)
6.3.2 United States Preclinical CRO Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Preclinical CRO Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Preclinical CRO Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Preclinical CRO Treatment Revenue by Type (2016-2026)
7.2 Europe Preclinical CRO Treatment Revenue by Application (2016-2026)
7.3 Europe Preclinical CRO Treatment Market Size by Country
7.3.1 Europe Preclinical CRO Treatment Revenue by Country (2016-2026)
7.3.2 Germany Preclinical CRO Treatment Market Size and Forecast (2016-2026)
7.3.3 France Preclinical CRO Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Preclinical CRO Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Preclinical CRO Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Preclinical CRO Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Preclinical CRO Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Preclinical CRO Treatment Market Size by Region
8.3.1 Asia-Pacific Preclinical CRO Treatment Revenue by Region (2016-2026)
8.3.2 China Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8.3.5 India Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Preclinical CRO Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Preclinical CRO Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Preclinical CRO Treatment Revenue by Type (2016-2026)
9.2 South America Preclinical CRO Treatment Revenue by Application (2016-2026)
9.3 South America Preclinical CRO Treatment Market Size by Country
9.3.1 South America Preclinical CRO Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Preclinical CRO Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Preclinical CRO Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Preclinical CRO Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Preclinical CRO Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Preclinical CRO Treatment Market Size by Country
10.3.1 Middle East & Africa Preclinical CRO Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Preclinical CRO Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Preclinical CRO Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Preclinical CRO Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Preclinical CRO Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Preclinical CRO Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Preclinical CRO Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Preclinical CRO Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Preclinical CRO Treatment Revenue Market Share by Region (2021-2026)
Table 6. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Laboratories Major Business
Table 8. Charles River Laboratories Preclinical CRO Treatment Product and Solutions
Table 9. Charles River Laboratories Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Laboratory Corporation of America Corporate Information, Head Office, and Major Competitors
Table 11. Laboratory Corporation of America Major Business
Table 12. Laboratory Corporation of America Preclinical CRO Treatment Product and Solutions
Table 13. Laboratory Corporation of America Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Envigo Corporate Information, Head Office, and Major Competitors
Table 15. Envigo Major Business
Table 16. Envigo Preclinical CRO Treatment Product and Solutions
Table 17. Envigo Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Eurofins Scientific Major Business
Table 20. Eurofins Scientific Preclinical CRO Treatment Product and Solutions
Table 21. Eurofins Scientific Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. PRA Health Science Corporate Information, Head Office, and Major Competitors
Table 23. PRA Health Science Major Business
Table 24. PRA Health Science Preclinical CRO Treatment Product and Solutions
Table 25. PRA Health Science Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Wuxi AppTec Corporate Information, Head Office, and Major Competitors
Table 27. Wuxi AppTec Major Business
Table 28. Wuxi AppTec Preclinical CRO Treatment Product and Solutions
Table 29. Wuxi AppTec Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Medpace Corporate Information, Head Office, and Major Competitors
Table 31. Medpace Major Business
Table 32. Medpace Preclinical CRO Treatment Product and Solutions
Table 33. Medpace Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pharmaceutical Product Development Corporate Information, Head Office, and Major Competitors
Table 35. Pharmaceutical Product Development Major Business
Table 36. Pharmaceutical Product Development Preclinical CRO Treatment Product and Solutions
Table 37. Pharmaceutical Product Development Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Paraxel Corporate Information, Head Office, and Major Competitors
Table 39. Paraxel Major Business
Table 40. Paraxel Preclinical CRO Treatment Product and Solutions
Table 41. Paraxel Preclinical CRO Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Preclinical CRO Treatment Revenue (USD Million) by Players (2019-2021)
Table 43. Global Preclinical CRO Treatment Revenue Share by Players (2019-2021)
Table 44. Breakdown of Preclinical CRO Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Preclinical CRO Treatment Players Head Office, Products and Services Provided
Table 46. Preclinical CRO Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Preclinical CRO Treatment New Entrants and Expansion Plans
Table 48. Global Preclinical CRO Treatment Revenue (USD Million) by Type (2016-2021)
Table 49. Global Preclinical CRO Treatment Revenue Share by Type (2016-2021)
Table 50. Global Preclinical CRO Treatment Revenue Forecast by Type (2021-2026)
Table 51. Global Preclinical CRO Treatment Revenue by Application (2016-2021)
Table 52. Global Preclinical CRO Treatment Revenue Forecast by Application (2021-2026)
Table 53. North America Preclinical CRO Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Preclinical CRO Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Preclinical CRO Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Preclinical CRO Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Preclinical CRO Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Preclinical CRO Treatment Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Preclinical CRO Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Preclinical CRO Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Preclinical CRO Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Preclinical CRO Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Preclinical CRO Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Preclinical CRO Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Preclinical CRO Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Preclinical CRO Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Preclinical CRO Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Preclinical CRO Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Preclinical CRO Treatment Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Preclinical CRO Treatment Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Preclinical CRO Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Preclinical CRO Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Preclinical CRO Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Preclinical CRO Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Preclinical CRO Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Preclinical CRO Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Preclinical CRO Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Preclinical CRO Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Preclinical CRO Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Preclinical CRO Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Preclinical CRO Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Preclinical CRO Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Preclinical CRO Treatment Picture
Figure 2. Global Preclinical CRO Treatment Revenue Market Share by Type in 2020
Figure 3. Bioanalysis and DMPK Studies
Figure 4. Toxicology Testing
Figure 5. Others
Figure 6. Preclinical CRO Treatment Revenue Market Share by Application in 2020
Figure 7. Biopharmaceutical Companies Picture
Figure 8. Government and Academic Institutes Picture
Figure 9. Medical Device Companies Picture
Figure 10. Global Preclinical CRO Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Preclinical CRO Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Preclinical CRO Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Preclinical CRO Treatment Revenue Market Share by Region in 2020
Figure 14. North America Preclinical CRO Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Preclinical CRO Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Preclinical CRO Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Preclinical CRO Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Preclinical CRO Treatment Market Drivers
Figure 19. Preclinical CRO Treatment Market Restraints
Figure 20. Preclinical CRO Treatment Market Trends
Figure 21. Charles River Laboratories Recent Developments and Future Plans
Figure 22. Laboratory Corporation of America Recent Developments and Future Plans
Figure 23. Envigo Recent Developments and Future Plans
Figure 24. Eurofins Scientific Recent Developments and Future Plans
Figure 25. PRA Health Science Recent Developments and Future Plans
Figure 26. Wuxi AppTec Recent Developments and Future Plans
Figure 27. Medpace Recent Developments and Future Plans
Figure 28. Pharmaceutical Product Development Recent Developments and Future Plans
Figure 29. Paraxel Recent Developments and Future Plans
Figure 31. Global Preclinical CRO Treatment Revenue Share by Players in 2020
Figure 32. Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Preclinical CRO Treatment Revenue Market Share in 2020
Figure 34. Global Top 10 Players Preclinical CRO Treatment Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Preclinical CRO Treatment Revenue Share by Type in 2020
Figure 37. Global Preclinical CRO Treatment Market Share Forecast by Type (2021-2026)
Figure 38. Global Preclinical CRO Treatment Revenue Share by Application in 2020
Figure 39. Global Preclinical CRO Treatment Market Share Forecast by Application (2021-2026)
Figure 40. North America Preclinical CRO Treatment Sales Market Share by Type (2016-2026)
Figure 41. North America Preclinical CRO Treatment Sales Market Share by Application (2016-2026)
Figure 42. North America Preclinical CRO Treatment Revenue Market Share by Country (2016-2026)
Figure 43. United States Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Preclinical CRO Treatment Sales Market Share by Type (2016-2026)
Figure 47. Europe Preclinical CRO Treatment Sales Market Share by Application (2016-2026)
Figure 48. Europe Preclinical CRO Treatment Revenue Market Share by Country (2016-2026)
Figure 49. Germany Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Preclinical CRO Treatment Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Preclinical CRO Treatment Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Preclinical CRO Treatment Revenue Market Share by Region (2016-2026)
Figure 57. China Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Preclinical CRO Treatment Sales Market Share by Type (2016-2026)
Figure 64. South America Preclinical CRO Treatment Sales Market Share by Application (2016-2026)
Figure 65. South America Preclinical CRO Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Preclinical CRO Treatment Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Preclinical CRO Treatment Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Preclinical CRO Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Preclinical CRO Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の前臨床CRO治療市場規模・現状・予測（2021年-2027年） A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the p…- 世界の前臨床X線画像市場規模・現状・予測（2021年-2027年） An x-ray (radiograph) is a penetrating form of high-energy electromagnetic radiation and noninvasive medical test that helps physicians diagnose and treat medical conditions. Market Analysis and Insights: Global Preclinical X-ray Imaging Market The global Preclinical X-ray Imaging market size is pr…
- 世界の陽電子放出断層撮影（PET）市場規模・現状・予測（2021年-2027年） PET creates three-dimensional (3D) images of a subject using radioactive tracers – molecules bound to a radioactive isotope – that are usually injected intravenously. The carrier molecule can bind to specific proteins, receptors, and biomolecular pathways in the body, to quantify a specific biologic…
- 世界の前臨床画像（In-VIVO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preclinical Imaging (In-VIVO) Market The global Preclinical Imaging (In-VIVO) market size is projected to reach US$ 862.1 million by 2026, from US$ 675 million in 2019, at a CAGR of 3.5% during 2021-2026. With industry-standard accuracy in analysis and high data …
- 世界の前臨床脳画像市場規模・現状・予測（2021年-2027年） Preclinical imaging is a technique used to monitor animals for research purposes such as in new drug development. Preclinical imaging includes many different imaging modalities, in which only few are suitable for imaging small animals, and others can be used in large animals. Market Analysis and Ins…